Akari Therapeutics (AKTX) Net Income (QoQ) (2014 - 2026)
Akari Therapeutics (AKTX) Net Income (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.84% |
| Dec 31, 2025 | 17.22% |
| Sep 30, 2025 | -101.96% |
| Jun 30, 2025 | 14.47% |
| Mar 31, 2025 | 1.78% |
| Dec 31, 2024 | -30.29% |
| Sep 30, 2024 | 61.39% |
| Jun 30, 2024 | -25.24% |
| Mar 31, 2024 | -17.78% |
| Dec 31, 2023 | -104.05% |
| Sep 30, 2023 | 45.68% |
| Jun 30, 2023 | -0.48% |
| Dec 31, 2020 | -2,761.96% |
| Sep 30, 2020 | 95.93% |
| Jun 30, 2020 | -19.99% |
| Mar 31, 2020 | 37.04% |
| Dec 31, 2019 | -151.17% |
| Sep 30, 2019 | 48.35% |
| Jun 30, 2019 | -45,623.84% |
| Mar 31, 2016 | -146.13% |